全球微胶囊 Omega-3 粉末市场 - 2023-2030
市场调查报告书
商品编码
1359946

全球微胶囊 Omega-3 粉末市场 - 2023-2030

Global Microencapsulated Omega-3 Powders Market - 2023-2030

出版日期: | 出版商: DataM Intelligence | 英文 212 Pages | 商品交期: 约2个工作天内

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

概述 :

全球微胶囊 Omega-3 粉末市场于 2022 年达到 166 亿美元,预计到 2030 年将达到 305 亿美元,2023-2030 年预测期间复合年增长率为 7.9%。

Omega-3 脂肪酸因其支持心血管健康的潜力(尤其是降低心臟病风险)而受到广泛关注。它们也与认知健康的增强有关,包括记忆力的改善和情绪调节。在消费者积极寻求有助于整体健康的产品的时代,微胶囊 omega-3 粉末提供了一种便捷有效的途径。

此外,市场的扩张得益于植物性饮食和生活方式的转变,促进了对植物源 omega-3 来源的需求不断增长,特别是来自藻类的微胶囊粉末。这与道德、环境和健康考量无缝结合,从而推动市场的成长轨迹。

随着消费者继续优先考虑积极的健康措施并寻求实用的饮食解决方案,微胶囊 Omega-3 粉末市场有望持续扩张,为更广泛的膳食补充剂行业做出宝贵贡献。微胶囊omega-3粉末的强化食品和饮料应用占了30%以上的市场。

同样,北美在微胶囊 Omega-3 粉末市场上占据主导地位,占据了超过 1/3 的最大市场份额。随着美国人越来越重视自己的健康并积极管理自己的福祉,对提供这些必需营养素的微胶囊 omega-3 粉末等补充剂的需求持续飙升。

动态:

健康和保健意识

世界各地的人们越来越关注自己的健康,尤其是在做出日常食品决策时。新加坡认证委员会报告指出,美国健康相关产品的销售量有所成长(2020 年至 2021 年成长 31%),包括非处方药以及营养/健康食品和饮料。

这一热潮可能是由于 48% 的全球消费者在日常活动中积极选择保持健康。客户也期望企业(例如食品生产商和零售商)和政府组织采取积极措施来促进地球的健康和福祉。事实上,大多数受访的国际消费者 (72%) 认为,企业在确保每个人都能以实惠的价格获得健康食品方面发挥着重要作用。

全球医疗保健支出的增加(2020 年为8.8% 至9.9%)、糖法规(50 个国家征收糖关税)和标籤法(4 个经合组织国家强制执行营养标籤)只是导致消费者对健康需求增加的几个趋势。生活方式的改变,反过来又需要微胶囊 omega-3 粉末。

增强稳定性和保质期

稳定性的提高和保质期的延长构成了微胶囊 omega-3 粉末市场的独特且具有影响力的力量。 Omega-3 脂肪酸以其增强健康的特性而闻名,但历史上一直面临着易降解和氧化的问题。这些挑战通常会导致 omega-3 补充剂和强化食品变质且效果较差。

市场上的主要参与者正在创新地扩大他们的产品组合。 2022 年 9 月,菲仕兰成分推出三种微囊长链多元不饱和脂肪酸 (LCPUFA)、两种 DHA 成分和一种 ARA 成分,用于新生儿配方​​奶粉中。 DHA成分来自海藻油,ARA成分来自真菌油。这两款产品均属于 Vana-Sana 系列。

在确保 omega-3 稳定性的情况下,製造商可以使其产品多样化。微胶囊粉末可以融入更广泛的食品和饮料产品中,包括那些具有延长保质期的产品,例如谷物、零食和代餐奶昔。微胶囊 omega-3 粉末为在日常食品中添加必需脂肪酸而打开了大门,同时又不影响产品品质。这种转变将传统食品转变为功能性的、以健康为导向的选择。

消费者意识有限

与鱼油胶囊或液体补充剂等更成熟的形式相比,微胶囊 Omega-3 粉末代表了膳食补充剂领域相对较新的产品。因此,许多消费者可能不了解微胶囊粉末的存在和好处。不熟悉这种产品形式可能会带来重大挑战,因为消费者倾向于选择他们熟悉且已有知识的选择。

传达微胶囊 Omega-3 粉末的优点可能很复杂。虽然这些粉末具有独特的优点,例如提高稳定性、减少气味和味道问题以及提高 omega-3 脂肪酸的生物利用度,但以简单明了的方式向消费者阐明这些优点可能会很困难。这种复杂性可能会阻碍消费者做出明智决定的能力,并可能导致他们选择更熟悉的补充剂形式。

成本复杂性

挑战的主要面向在于微胶囊化过程本身的复杂性。该过程需要先进的方法将 omega-3 油包裹在保护层中,从而提高稳定性和生物利用度。这些方法需要专门的设备和熟练的劳动力,从而增加了生产费用。此外,封装过程中使用的原料,例如壁材和稳定剂,可能很昂贵。

製造商需要在研发方面进行大量投资,以完善封装技术、维持严格的品质标准并确保产品功效。因此,製造微胶囊 Omega-3 粉末的相关费用往往超过鱼油胶囊或液体形式等传统 Omega-3 补充剂。

当製造商努力在提供高品质微胶囊 omega-3 粉末和提供有竞争力的价格之间取得平衡时,就会出现定价挑战。生产成本上升往往会导致产品价格上涨,这可能会限制市场对注重成本的消费者的吸引力。在消费者热衷于节约并可能选择更经济的 omega-3 补充剂替代品的市场中,这成为一个相关问题。

目录

第 1 章:方法与范围

  • 研究方法论
  • 报告的研究目的和范围

第 2 章:定义与概述

第 3 章:执行摘要

  • 按类型的片段
  • 按配销通路分類的片段
  • 按应用片段
  • 最终使用者的片段
  • 按地区分類的片段

第 4 章:动力学

  • 影响因素
    • 司机
      • 健康和保健意识
      • 增强稳定性和保质期
    • 限制
      • 消费者意识有限
      • 成本复杂性
    • 机会
    • 影响分析

第 5 章:产业分析

  • 波特五力分析
  • 供应链分析
  • 定价分析
  • 监管分析
  • 俄乌战争影响分析
  • DMI 意见

第 6 章:COVID-19 分析

  • COVID-19 分析
    • 新冠疫情爆发前的情景
    • 新冠疫情期间的情景
    • 新冠疫情后的情景
  • COVID-19 期间的定价动态
  • 供需谱
  • 疫情期间政府与市场相关的倡议
  • 製造商的策略倡议
  • 结论

第 7 章:按类型

  • α-亚麻油酸
  • 二十碳五烯酸
  • 二十二碳六烯酸

第 8 章:按配销通路

  • 超市/大卖场
  • 便利商店
  • 专卖店
  • 电子商务
  • 其他的

第 9 章:按应用

  • 膳食补充剂
  • 强化食品和饮料
  • 婴幼儿配方奶粉
  • 药品
  • 运动营养
  • 化妆品和个人护理产品
  • 其他的

第 10 章:最终用户

  • 孩子们
  • 成年人
  • 老年人

第 11 章:按地区

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 俄罗斯
    • 欧洲其他地区
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地区
  • 亚太
    • 中国
    • 印度
    • 日本
    • 澳洲
    • 亚太其他地区
  • 中东和非洲

第 12 章:竞争格局

  • 竞争场景
  • 市场定位/份额分析
  • 併购分析

第 13 章:公司简介

  • ADM
    • 公司简介
    • 产品组合和描述
    • 财务概览
    • 主要进展
  • FrieslandCampina
  • BASF SE
  • KD Pharma Group
  • Novotech Nutraceuticals Inc.
  • WINCOBEL
  • Aker BioMarine
  • Croda International Plc
  • DSM
  • Ecovatec Solutions Inc.

第 14 章:附录

简介目录
Product Code: FB6989

Overview:

Global Microencapsulated Omega-3 Powders Market reached US$ 16.6 billion in 2022 and is expected to reach US$ 30.5 billion by 2030, growing with a CAGR of 7.9% during the forecast period 2023-2030.

Omega-3 fatty acids have garnered substantial attention due to their potential in supporting cardiovascular health, notably by mitigating the risk of heart diseases. They are also associated with cognitive health enhancements, including memory improvement and mood regulation. In an era where consumers actively seek products that contribute to their overall well-being, microencapsulated omega-3 powders offer a convenient and effective avenue.

Additionally, the market's expansion is bolstered by the shift towards plant-based diets and lifestyles, fostering a growing demand for plant-derived omega-3 sources, particularly microencapsulated powders derived from algae. This aligns seamlessly with ethical, environmental, and health considerations, thereby propelling the market's growth trajectory.

As consumers continue to prioritize proactive health measures and seek practical dietary solutions, the microencapsulated omega-3 powders market stands poised for sustained expansion, making a valuable contribution to the broader dietary supplement industry. The fortified food and beverages application of microencapsulated omega-3 powders account for over 30% of the market share.

Similarly, North America dominates the microencapsulated omega-3 powders market, capturing the largest market share of over 1/3rd. As Americans increasingly prioritize their health and proactively manage their well-being, the demand for supplements like microencapsulated omega-3 powders, which deliver these essential nutrients, continues to soar.

Dynamics:

Health and Wellness Awareness

People are paying more attention to their own health and wellness all across the world, especially when making everyday food product decisions. The Singapore Accreditation Council report states that sales of health-related products in the U.S. have increased (31% growth from 2020-2021), including over-the-counter medications and nutritional/healthier food and beverages.

The upsurge can be due to the 48% of global consumers who actively choose to maintain their wellness as they go about their daily activities. Customers also anticipate businesses (such food producers and retailers) and governmental organizations to take proactive steps to advance the health and wellbeing of the planet. In fact, the majority of surveyed international consumers (72%) thought that businesses had a big part to play in making sure that everyone could access healthy food at an accessible price.

The increased global healthcare expenditures (8.8% to 9.9% in 2020), sugar regulations (50 nations imposed sugar tariffs), and label laws (4 OECD countries enforce nutritional labelling) are just a few trends that have led to increased consumer demand towards healthy lifestyles, which in turn, there is a demand for microencapsulated omega-3 powders.

Enhanced Stability and Shelf Life

Improved stability and prolonged shelf life constitute a distinctive and influential force behind the microencapsulated omega-3 powders market. Omega-3 fatty acids, renowned for their health-enhancing properties, have historically faced issues related to susceptibility to degradation and oxidation. These challenges often result in rancid and less effective omega-3 supplements and fortified foods.

Key players in the market are innovatively expanding their portfolios. In September 2022, three microencapsulated long-chain polyunsaturated fatty acids (LCPUFA), two DHA components and one ARA ingredient, have been introduced by FrieslandCampina components for use in newborn milk formulas. The DHA ingredients come from algal oil, while the ARA ingredients come from fungus oil. Both products are part of the Vana-Sana line.

With the assurance of omega-3 stability, manufacturers can diversify their product offerings. Microencapsulated powders can be incorporated into a broader spectrum of food and beverage products, including those with extended shelf lives, such as cereals, snacks, and meal replacement shakes. Microencapsulated omega-3 powders open doors to fortify everyday foods with essential fatty acids without compromising product quality. This transformation turns conventional foods into functional, health-oriented options.

Limited Consumer Awareness

Microencapsulated omega-3 powders represent a relatively recent addition to the dietary supplement arena when compared to more established forms like fish oil capsules or liquid supplements. Consequently, many consumers may not be acquainted with the existence and benefits of microencapsulated powders. The absence of familiarity with this product form can pose a significant challenge, as consumers tend to gravitate toward options they are comfortable with and have prior knowledge.

Conveying the advantages of microencapsulated omega-3 powders can be intricate. While these powders offer distinctive benefits such as heightened stability, diminished odor and taste concerns, and improved bioavailability of omega-3 fatty acids, articulating these advantages to consumers in a straightforward and concise manner can be demanding. This complexity can hinder consumers' ability to make informed decisions and may lead them to opt for more familiar supplement forms.

Cost Complexity

A primary aspect of the challenge lies in the complexity of the microencapsulation process itself. This process entails advanced methodologies to encase omega-3 oils within protective layers, enhancing stability and bioavailability. These methodologies necessitate specialized equipment and a skilled workforce, thereby escalating production expenses. Furthermore, the raw materials utilized in the encapsulation procedure, such as wall materials and stabilizers, can be costly.

Manufacturers are required to make substantial investments in research and development to refine encapsulation technologies, maintain rigorous quality standards, and assure product efficacy. Consequently, the expense associated with manufacturing microencapsulated omega-3 powders tends to surpass that of traditional omega-3 supplements like fish oil capsules or liquid forms.

The pricing challenge arises when manufacturers endeavor to strike an equilibrium between delivering high-quality microencapsulated omega-3 powders and offering competitive pricing. Elevated production costs often translate into higher product prices, which might limit the market's attractiveness to cost-conscious consumers. This becomes a pertinent issue in markets where consumers are keen on economizing and may opt for more budget-friendly omega-3 supplement alternatives.

Segment Analysis:

The global microencapsulated omega-3 powders market is segmented based on type, distribution channel, application, end-user and region.

Fortified Food and Beverages Applications Fuel Surge in Microencapsulated Omega-3 Powders Market

The fortified food and beverages segment held 36.5% in the global market share. Fortified food and beverage choices provide a hassle-free means for individuals to meet their daily nutritional requirements. In today's fast-paced world, many people find it challenging to allocate time or inclination to consume separate dietary supplements. Fortified products like breakfast cereals, dairy alternatives, and functional beverages offer consumers an effortless way to seamlessly integrate crucial nutrients such as omega-3s into their diets.

Consumers are increasingly scrutinizing product labels and seeking out clean, transparent ingredient lists. Microencapsulation facilitates the utilization of natural ingredients and reduces reliance on synthetic preservatives, aligning well with the clean label trend. This aligns with health-conscious consumers who desire clarity about what they are consuming.

For manufacturers, fortifying foods and beverages with microencapsulated omega-3 powders presents prospects for innovation and setting their products apart. In a competitive landscape, offering fortified choices can distinguish brands and attract health-focused consumers, potentially leading to increased market share and brand loyalty.

In March 2021, Netherlands company Lus Health Ingredients (also known as LUS), which creates sustainable and plant-based ingredients, increased the selection of fat powders that are rich in omega 3, 6, and 9. The company claims that a rising number of consumers do not want to ingest dairy, glucose syrups, maltodextrin, or other components that are typically found in fat powders, which are most frequently used by those who follow a ketogenic diet.

Geographical Penetration:

Adoption of Healthy Supplements in the U.S.

The North America microencapsulated omega-3 powders market held the largest market share of 40.3% in 2022 in the microencapsulated omega-3 powders market analysis. A significant contributor to the rise in interest in microencapsulated omega-3 powders is the growing focus on health and wellbeing in the U.S. End users in this region are actively looking for products that provide a range of health benefits as they become more health conscious.

The mental health advantages of these essential fatty acids are also well documented, particularly aiding in cognitive function and possibly mood enhancement. North America's demographic landscape includes a significant aging population, with older individuals placing a premium on health and wellness. Omega-3s, with their associations with cognitive preservation and joint health, hold particular appeal for seniors.

People in the U.S. are prone to various chronic diseases. Data from TechTarget, Inc.'s Xtelligent Healthcare studies show that 133 million Americans, or 43% of the population, suffer from one or more chronic conditions. Patients with chronic illnesses and the people they care about suffer from a heavy load. Hence, consumers are opting for fortified food and beverages.

Competitive Landscape

The major global players in the market include ADM, FrieslandCampina, BASF SE, KD Pharma Group, Novotech Nutraceuticals Inc., WINCOBEL, Aker BioMarine, Croda International Plc, DSM and Ecovatec Solutions Inc.

COVID-19 Impact Analysis

The microencapsulated omega-3 powders market felt the consequences of the COVID-19 pandemic, experiencing both immediate disruptions and lasting alterations in consumer behavior and industry operations. Initially, the pandemic triggered supply chain hiccups as global trade restrictions and factory closures hampered the procurement of essential raw materials and the production of these powders. This led to bottlenecks in manufacturing and short-term price hikes as production costs increased.

Concurrently, a surge in demand for omega-3 powders driven by health-conscious consumers responding to the health crisis resulted in some suppliers struggling to meet the sudden upswing in orders. Nonetheless, as the pandemic evolved, the market adapted. Manufacturers expanded their production capacities, streamlined supply chains, and invested in innovative encapsulation technologies to meet surging demand.

Russia-Ukraine War Impact Analysis

The Russia-Ukraine conflict has introduced complex challenges to the microencapsulated omega-3 powders market, primarily by disrupting the global supply chain. Ukraine, a key player in the production of sunflower oil, a significant source of omega-3 fatty acids, has experienced agricultural disruptions and trade uncertainties. These disruptions have the potential to create shortages and price fluctuations for crucial raw materials required for the microencapsulation process.

Beyond the immediate supply chain disruptions, the Russia-Ukraine conflict has catalyzed changes in consumer behavior and prompted strategic responses from businesses in the microencapsulated omega-3 powders market. During times of geopolitical uncertainty, consumers often gravitate toward products perceived as stable and trustworthy. This trend may potentially boost demand for omega-3 powders, given their recognized health benefits.

By Type

  • Alpha-linolenic Acid
  • Eicosapentaenoic Acid
  • Docosahexaenoic Acid

By Distribution channel

  • Supermarkets/Hypermarkets
  • Convenience Stores
  • Specialty Stores
  • E-Commerce
  • Others

By Application

  • Dietary Supplements
  • Fortified foods and beverages
  • Infant Formula
  • Pharmaceuticals
  • Sports Nutrition
  • Cosmetics and Personal Care Products
  • Others

By End-User

  • Children
  • Adults
  • Seniors

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Russia
    • Rest of Europe
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • Rest of Asia-Pacific
  • Middle East and Africa

Key Developments

  • In September 2022, Three microencapsulated long-chain polyunsaturated fatty acids (LCPUFA), two DHA components and one ARA ingredient, have been launched by FrieslandCampina components for use in newborn milk formulas. The DHA ingredients come from algal oil, while the ARA ingredients come from fungus oil. Both products are part of the Vana-Sana line.
  • In April 2020, DSM introduced two new, premium lipid powders for newborn nourishment called DHASCO®-B and ARASCO® powders, each of which offers a minimum of 110 mg/g of either DHA (docosahexaenoic acid) or ARA (arachidonic acid). These powders, which can be added to infant and subsequent formulae as well as growing-up milk products, contain safe and acceptable sources of vegetarian DHA omega-3 and ARA omega-6.
  • In September 2020, Evonik has announced the extension of its AvailOm® platform of high-load omega-3 powders to support the development of superior algal or fish-oil-based dietary supplement formulations by nutraceutical firms. Every one of the three grades is designed to meet the special application needs for good ageing, pregnancy, and motherhood, as well as the lifestyle requirements of consumer groups including vegans and vegetarians.

Why Purchase the Report?

  • To visualize the global microencapsulated omega-3 powders market segmentation based on type, distribution channel, application, end-user and region, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of microencapsulated omega-3 powders market-level with all segments.
  • The PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as Excel consisting of key products of all the major players.

The global Microencapsulated Omega-3 Powders Market Report would provide approximately 69 tables, 73 figures and 212 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet By Type
  • 3.2. Snippet By Distribution Channel
  • 3.3. Snippet By Application
  • 3.4. Snippet By End-User
  • 3.5. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Health and Wellness Awareness
      • 4.1.1.2. Enhanced Stability and Shelf Life
    • 4.1.2. Restraints
      • 4.1.2.1. Limited Consumer Awareness
      • 4.1.2.2. Cost Complexity
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. Russia-Ukraine War Impact Analysis
  • 5.6. DMI Opinion

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID
    • 6.1.2. Scenario During COVID
    • 6.1.3. Scenario Post COVID
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers' Strategic Initiatives
  • 6.6. Conclusion

7. By Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 7.1.2. Market Attractiveness Index, By Type
  • 7.2. Alpha-linolenic Acid*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Eicosapentaenoic Acid
  • 7.4. Docosahexaenoic Acid

8. By Distribution Channel

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
  • 8.2. Market Attractiveness Index, By Distribution Channel
  • 8.3. Supermarkets/Hypermarkets*
    • 8.3.1. Introduction
    • 8.3.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.4. Convenience Stores
  • 8.5. Specialty Stores
  • 8.6. E-Commerce
  • 8.7. Others

9. By Application

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.1.2. Market Attractiveness Index, By Application
  • 9.2. Dietary Supplements*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Fortified foods and beverages
  • 9.4. Infant Formula
  • 9.5. Pharmaceuticals
  • 9.6. Sports Nutrition
  • 9.7. Cosmetics and Personal Care Products
  • 9.8. Others

10. By End-User

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.1.2. Market Attractiveness Index, By End-User
  • 10.2. Children*
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 10.3. Adults
  • 10.4. Seniors

11. By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.2.7.1. U.S.
      • 11.2.7.2. Canada
      • 11.2.7.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.3.7.1. Germany
      • 11.3.7.2. UK
      • 11.3.7.3. France
      • 11.3.7.4. Italy
      • 11.3.7.5. Russia
      • 11.3.7.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.4.7.1. Brazil
      • 11.4.7.2. Argentina
      • 11.4.7.3. Rest of South America
  • 11.5. Asia-Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.5.7.1. China
      • 11.5.7.2. India
      • 11.5.7.3. Japan
      • 11.5.7.4. Australia
      • 11.5.7.5. Rest of Asia-Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

12. Competitive Landscape

  • 12.1. Competitive Scenario
  • 12.2. Market Positioning/Share Analysis
  • 12.3. Mergers and Acquisitions Analysis

13. Company Profiles

  • 13.1. ADM
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio and Description
    • 13.1.3. Financial Overview
    • 13.1.4. Key Developments
  • 13.2. FrieslandCampina
  • 13.3. BASF SE
  • 13.4. KD Pharma Group
  • 13.5. Novotech Nutraceuticals Inc.
  • 13.6. WINCOBEL
  • 13.7. Aker BioMarine
  • 13.8. Croda International Plc
  • 13.9. DSM
  • 13.10. Ecovatec Solutions Inc.

LIST NOT EXHAUSTIVE

14. Appendix

  • 14.1. About Us and Services
  • 14.2. Contact Us